4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Geron Corporation (GERN) operates in the Biotechnology industry and is headquartered in Foster City, United States with about 258 employees. Its market capitalization is roughly $998 million. In the fiscal year ended 2025-12-31, GERN reported $184M in revenue and ($84M) in net income.
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
Interactive charts & full statements → Open the GERN valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $184M | $77M | $0M | $1M | — |
| Gross Profit | $179M | $76M | $0M | $1M | — |
| Operating Income (EBIT) | ($52M) | ($174M) | ($194M) | ($139M) | — |
| Net Income | ($84M) | ($175M) | ($184M) | ($142M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $52M | $48M | $47M | $49M | $40M | — |
| Gross Profit | $50M | $47M | $46M | $48M | $38M | — |
| Operating Income (EBIT) | ($0M) | ($8M) | ($14M) | ($12M) | ($17M) | — |
| Net Income | ($4M) | ($29M) | ($18M) | ($16M) | ($20M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $570M | $594M | $394M | $191M | — |
| Total Liabilities | $345M | $314M | $146M | $111M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GERN viewer.
About TickerBase · Data methodology & sources